Papaefthymiou Apostolis, Landi Rosario, Arvanitakis Marianna, Tringali Andrea, Gkolfakis Paraskevas
Digestive Disease & Surgery institute, Cleveland Clinic London, UK.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore, Centre for Endoscopic Research Therapeutics and Training (CERTT), Rome, Italy.
Best Pract Res Clin Gastroenterol. 2025 Feb;74:101976. doi: 10.1016/j.bpg.2025.101976. Epub 2025 Jan 4.
Endoscopic retrograde cholangiopancreatography (ERCP) was initially introduced in clinical practice as diagnostic tool. However, the presence of adverse events and the development of non-invasive techniques, such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS), limited its role as a stand-alone diagnostic choice, modifying its role to the leader of therapeutic pancreatobiliary endoscopy. Despite technological advances, there are still conditions where non-invasive diagnostic modalities are inconclusive, such as indeterminate biliary and pancreatic duct strictures, primary sclerosing cholangitis functional stenoses, intraductal papillary mucinous neoplasms (IPMNs) and paediatric indications, such as congenital anatomical abnormalities. This narrative review aimed to identify and analyse indications of diagnostic ERCP, without the need for therapeutic manipulations.
内镜逆行胰胆管造影术(ERCP)最初作为一种诊断工具引入临床实践。然而,不良事件的存在以及磁共振胰胆管造影(MRCP)和内镜超声(EUS)等非侵入性技术的发展,限制了其作为独立诊断选择的作用,使其角色转变为治疗性胰胆管内镜检查的主导方法。尽管技术有所进步,但在某些情况下,非侵入性诊断方法仍无法得出明确结论,如胆管和胰管狭窄不明确、原发性硬化性胆管炎功能性狭窄、导管内乳头状黏液性肿瘤(IPMN)以及儿科适应症,如先天性解剖异常。本叙述性综述旨在识别和分析无需进行治疗操作的诊断性ERCP的适应症。